PYOTT DAVID E I
SEC CIK 1051578 · EDGAR
BoughtSold
Most active insiders at TARS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Azamian Bobak R. | Pres, CEO, Board COB, Dir | — | $5.51M |
| 2 | LINK WILLIAM J PHD | Dir | — | $4.48M |
| 3 | Whitfield Dianne C. | CHRO | — | $2.69M |
| 4 | Lin Elizabeth Yeu | Chief Medical Off | — | $2.36M |
| 5 | Neervannan Seshadri | COO | — | $2.00M |
| 6 | Farrow Jeffrey S | See Remarks | — | $1.32M |
| 7 | Mottiwala Aziz | Chief Commercial Off | — | $892.5K |
| 8 | Wahl Bryan | GC | — | $850.4K |
| 9 | Goodrich Katherine | Dir | — | $183.4K |
| 10 | Goldberg Andrew D. | Dir | — | — |
| 14 | PYOTT DAVID E I | Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-09-17 16:47 | 2026-09-15 | TARS | Tarsus Pharmaceuticals, Inc. | PYOTT DAVID E I | Dir | M - OptEx | — | +201 | 9,575 | +2% | — |
| DT | 2026-06-03 16:25 | 2026-06-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Dir | M - OptEx | $0.00 | +3,830 | 5,412 | +242% | $0 |
| DMT | 2026-06-03 16:25 | 2026-06-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Dir | S - Sale+OE | $299.18 | -3,830 | 1,582 | -71% | -$1.15M |
| D | 2026-05-22 16:14 | 2026-05-20 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Dir | A - Grant | $0.00 | +671 | 1,582 | +74% | $0 |
| D | 2026-04-28 16:23 | 2026-04-24 | TARS | Tarsus Pharmaceuticals, Inc. | PYOTT DAVID E I | Dir | M - OptEx | — | +1,383 | 1,383 | New | — |
| D | 2025-05-12 | 2025-05-08 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Dir | A - Grant | $0.00 | +775 | 911 | +570% | $0 |
| D | 2025-03-25 | 2025-03-24 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Dir | M - OptEx | $88.95 | +7,440 | 7,576 | +5,471% | +$661.8K |
| D | 2025-03-25 | 2025-03-24 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Dir | S - Sale+OE | $299.00 | -7,440 | 136 | -98% | -$2.22M |
| DM | 2024-06-26 | 2024-06-24 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Dir | M - OptEx | $80.76 | +32.5K | 32.6K | +23,860% | +$2.62M |
| DM | 2024-06-26 | 2024-06-24 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Dir | S - Sale+OE | $220.69 | -32.5K | 7,606 | -81% | -$7.16M |
| 2024-05-23 | 2024-05-21 | BMRN | BIOMARIN PHARMACEUTICAL INC | PYOTT DAVID E I | Dir | A - Grant | $0.00 | +4,720 | 49.8K | +10% | $0 | |
| 2023-05-24 | 2023-05-23 | BMRN | BIOMARIN PHARMACEUTICAL INC | PYOTT DAVID E I | Dir | A - Grant | $0.00 | +4,190 | 45.0K | +10% | $0 | |
| D | 2023-02-27 | 2023-02-23 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Dir | M - OptEx | $0.00 | +136 | 136 | New | $0 |
| 2022-05-26 | 2022-05-24 | BMRN | BIOMARIN PHARMACEUTICAL INC | PYOTT DAVID E I | Dir | A - Grant | $0.00 | +4,980 | 40.8K | +14% | $0 |
Purchase Sale Sale after option exercise All abbreviations